Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-019434

Options or other derivatives

  • CHIEF OPERATING OFFICER acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bausch Christoph Lawrence CHIEF OPERATING OFFICER 2024-02-21 Grant or award · Employee Stock Option (right to buy) +140,000 140,000 D
Loading xslF345X05/ownership.xml…